HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
99mTc-hR3 monoclonal antibody
a humanized immunoconjugate directed towards the epidermal growth factor receptor
Also Known As:
99mTc-hR3; DiaCIM; monoclonal antibody 99mTc-hR3
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Organometallic Compounds: 64
Organotechnetium Compounds: 1
99mTc-hR3 monoclonal antibody: 1
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Blood Proteins: 12459
Serum Globulins: 553
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Humanized Monoclonal Antibodies: 217
99mTc-hR3 monoclonal antibody: 1
Immunoproteins: 43
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Humanized Monoclonal Antibodies: 217
99mTc-hR3 monoclonal antibody: 1
Globulins: 3062
Serum Globulins: 553
Immunoglobulins: 30480
Antibodies: 133716
Monoclonal Antibodies: 56412
Humanized Monoclonal Antibodies: 217
99mTc-hR3 monoclonal antibody: 1
Experts
1.
Spicer, James
: 1 article (04/2005)
Related Diseases
1.
Pancreatic Neoplasms (Pancreatic Cancer)
04/01/2005 - "
A joint venture between YM BioSciences (formerly York Medical) and The Center of Molecular Immunology is collaborating with Oncoscience in Europe for the development of a humanized monoclonal antibody, nimotuzumab, for the potential treatment (TheraCIM and RadioTheraCIM) and diagnosis (DiaCIM) of cancers of epithelial origin, such as breast, lung, head and neck, and pancreatic cancer.
"
2.
Neoplasms (Cancer)
04/01/2005 - "
A joint venture between YM BioSciences (formerly York Medical) and The Center of Molecular Immunology is collaborating with Oncoscience in Europe for the development of a humanized monoclonal antibody, nimotuzumab, for the potential treatment (TheraCIM and RadioTheraCIM) and diagnosis (DiaCIM) of cancers of epithelial origin, such as breast, lung, head and neck, and pancreatic cancer.
"
Related Drugs and Biologics
1.
Monoclonal Antibodies
2.
TheraCIM
3.
nimotuzumab